22nd Century Plans Reverse Stock Split To Regain Nasdaq Compliance
22nd Century Group, Inc (NASDAQ: XXII) plans to
Biotricity Announces 1-For-6 Reverse Stock Split
Biotricity Holdings, Inc. ("Biotricity" or the "Company") (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today it will effect a reverse stock split of its common
Advanced Health Intelligence Announced Implementation of ADS Ratio Change With Effect Of 1:4 Reverse ADS Split
- Advanced Health Intelligence Ltd (NASDAQ:AHI) (“Advanced Health Intelligence”, “AHI” or the “Company”) announces today that its planned ratio change of the Company’s American
Doma 1-For-25 Reverse Stock Split To Become Effective On June 29, 2023
Doma Holdings, Inc. (NYSE:DOMA) ("Doma" or the "Company") today announced that it had filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of
Addentax Group Corp. Announces 1-For-10 Reverse Share Split, Expected To Become Effective On June 30, 2023
Addentax Group Corp. ("Addentax" or the "Company") (NASDAQ:ATXG), an integrated service provider focusing on garment manufacturing, logistics service, property management and subleasing, today
Inhibikase Therapeutics Announces A 1-For-6 Reverse Stock Split
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease
Evelo Biosciences Announces 1-For-20 Reverse Stock Split Expected To Begin Trading On A Split-adjusted Basis On June 30, 2023
– EVLO common stock expected to begin trading on a split-adjusted basis on June 30, 2023 –
CAMBRIDGE, Mass., June 29, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (NASDAQ:EVLO), a clinical
Sphere 3D Announces 1-For-7 Share Consolidation; Will Begin Trading On A Post-Consolidation Basis On June 29, 2023
Sphere 3D Corp. (NASDAQ:ANY) ("Sphere 3D" or the "Company"), dedicated to becoming the leading carbon-neutral Bitcoin mining company operating at an industrial scale, today announced that it
Allarity Therapeutics Announces 1-For-40 Reverse Stock Split Of Common Stock; Will Begin Trading On A Post-Split Adjusted Basis On June 29, 2023
Allarity Therapeutics, Inc. (NASDAQ:ALLR) ("Allarity" or the "Company"), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific
Reported June 27, Allarity Therapeutics Announces Clarification Of Effective Date For Reverse Stock Split Will Be Announced In Future Press Release
Allarity Therapeutics, Inc. (NASDAQ:ALLR) ("Allarity" or the "Company"), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific